POS1 COST-EFFECTIVENESS OF RISENDRONATE THERAPY COMPARED TO ALENDRONATE IN POST-MENOPAUSAL WOMEN AT HIGH RISK OF OSTEOPOROTIC FRACTURE- A TAIWAN ANALYSIS
Nov 1, 2004, 00:00 AM
10.1016/S1098-3015(10)65903-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)65903-7/fulltext
Section Title :
Section Order :
270
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65903-7&doi=10.1016/S1098-3015(10)65903-7